| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 194301-99-0 | 1H-Pyrido[2,3-f]-1,2,3,5-tetrazepine(9CI); 1H-Pyrido[2,3-f]-1,2,3,5-tetrazepine(9CI) |  | C6H5N5 | 詳情 | 供應商 | |
| 133310-19-7 | 1,2,4-Triazinium,3,5-diamino-6-(2,3-dichlorophenyl)-2-b-D-glucopyranuronosyl-; LamotrigineN2Glucuronide85%; LamotrigineN2glucuronide; lamotrigine2Nglucuronide; 3,5Diamino6(2,3dichlorophenyl)2Dglucopyranuronosyl1,2,4triazinium |  | C15H16Cl2N5O6 | 詳情 | 供應商 | |
| 267431-60-7 | 1-Pentalenol,2-(iminomethyl)-; 1-Pentalenol, 2-(iminomethyl)- (9CI) |  | C9H7NO | 詳情 | 供應商 | |
| 74461-64-6 | 1,2,4-Thiadiazole,5-chloro-3-(chloromethyl)-; 3-Chloromethyl-5-chloro-1,2,4-thiadiazole; 5-Chloro-3-(chloromethyl)-1,2,4-thiadiazole; NSC 330684 |  | C3H2Cl2N2S | 詳情 | 供應商 | |
| 56525-09-8 | 1,3,5-Triazine-2,4-diamine,6-chloro-N2-ethyl-N4-(1-methylethyl)-N2-nitroso-; 1,3,5-Triazine-2,4-diamine,6-chloro-N-ethyl-N'-(1-methylethyl)-N-nitroso- (9CI); N-Nitrosoatrazine |  | C8H13ClN6O | 詳情 | 供應商 | |
| 63937-39-3 | 1,3-Dioxolo[4,5-g]isoquinoline,5,6,7,8-tetrahydro-6-methyl-5-[2-(4-nitrophenyl)ethyl]-; 1,3-Dioxolo[4,5-g]isoquinoline,5,6,7,8-tetrahydro-6-methyl-5-(p-nitrophenethyl)- (7CI) |  | C19H20N2O4 | 詳情 | 供應商 | |
| 22277-73-2 | 1,4-Piperazinedipropanenitrile,hydrochloride (1:2); 1,4-Piperazinedipropanenitrile,dihydrochloride (9CI); 1,4-Piperazinedipropionitrile, dihydrochloride (8CI) |  | C10H16N4.2ClH | 詳情 | 供應商 | |
| 388565-58-0 | 1,8-Naphthyridine-3-carboxamide,N-[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)-; 1,8-Naphthyridine-3-carboxamide,N-[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)-(9CI) |  | C19H16F3N3O2 | 詳情 | 供應商 | |
| 79379-05-8 | 1H-Pyrazole,4-(2-chloroethyl)-3,5-dimethyl-; 4-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole |  | C7H11ClN2 | 詳情 | 供應商 | |
| 401938-43-0 | 1,8-Naphthyridin-2(1H)-one,3,3'-[[4-(dimethylamino)phenyl]methylene]bis[4-hydroxy-; 1,8-Naphthyridin-2(1H)-one,3,3-[[4-(dimethylamino)phenyl]methylene]bis[4-hydroxy-(9CI) |  | C25H21N5O4 | 詳情 | 供應商 | |
| 1120-60-1 | 1,3,2-Diazastannolidine(8CI,9CI); 1H-1,3,2-Diazastannole,tetrahydro- |  | C2H8N2Sn | 詳情 | 供應商 | |
| 887589-67-5 | 1-Azetidinecarboxylicacid, 3-[[(2-bromophenyl)amino]methyl]-, 1,1-dimethylethyl ester; 1-BOC-3-[(2-BROMOPHENYL-AMINO)-METHYL]-AZETIDINE |  | C15H21BrN2O2 | 詳情 | 供應商 | |
| 182823-26-3 | 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,2,3-dihydro-2-hydroxy-, (2R,11aS)-rel-; 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,2,3-dihydro-2-hydroxy-, cis- |  | C12H12N2O3 | 詳情 | 供應商 | |
| 138865-23-3 | 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione, 2,3-dihydro-, hydrate (1:2), (11aS)-; 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione, 2,3-dihydro-, dihydrate,(S)- (9CI) |  | C12H16N2O4 | 詳情 | 供應商 | |
| 193091-13-3 | 1-Piperazineaceticacid, 4-[(1,1-dimethylethoxy)carbonyl]-2-oxo-a,3-bis(phenylmethyl)-, (aS,3S)-; 1-Piperazineaceticacid, 4-[(1,1-dimethylethoxy)carbonyl]-2-oxo-a,3-bis(phenylmethyl)-, [S-(R*,R*)]- |  | C25H30N2O5 | 詳情 | 供應商 | |
| 811841-89-1 | 1-Piperidinecarboxylicacid, 4-amino-, 9H-fluoren-9-ylmethyl ester, hydrochloride (1:1); 1-Piperidinecarboxylicacid, 4-amino-, 9H-fluoren-9-ylmethyl ester, monohydrochloride (9CI) |  | C20H23ClN2O2 | 詳情 | 供應商 | |
| 204376-55-6 | 1-Piperidinecarboxylicacid, 4-oxo-, 9H-fluoren-9-ylmethyl ester; 1-Fmoc-4-piperidone; 1-[[[(9H-Fluoren-9-yl)methyl]oxy]carbonyl]-4-piperidone; N-Fmoc-4-piperidone |  | C20H19NO3 | 詳情 | 供應商 | |
| 113293-50-8 | 1,3,5-Triazine,1,3,5-trihexylhexahydro-; s-Triazine,1,3,5-trihexylhexahydro- (6CI) |  | C21H45N3 | 詳情 | 供應商 | |
| 805246-32-6 | 1H-Benz[g]indol-6-ol,2,3,3a,4,5,9b-hexahydro-1-methyl-, (3aR,9bS)-rel-; 1H-Benz[g]indol-6-ol,2,3,3a,4,5,9b-hexahydro-1-methyl-,(3aR,9bS)-rel-(9CI) |  | C13H17NO | 詳情 | 供應商 | |
| 805246-31-5 | 1H-Benz[g]indole,2,3,3a,4,5,9b-hexahydro-6-methoxy-1-methyl-, (3aR,9bS)-rel-; 1H-Benz[g]indole,2,3,3a,4,5,9b-hexahydro-6-methoxy-1-methyl-,(3aR,9bS)-rel-(9CI) |  | C14H19NO | 詳情 | 供應商 | |